Press Release: TwoXAR : twoXAR Pharmaceuticals Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311

MOUNTAIN VIEW, Calif., June 22, 2020 /PRNewswire/ -- twoXAR Pharmaceuticals, a drug discovery and development company focused on bringing first-in-class small molecules to market, today announced that preclinical data for its investigational treatment TXR-311 with a novel MOA demonstrated...